Dysferlinopathies

Luis Vernengo, Luisa Carrasco, María Mirta Rodríguez, Corrado Angelini

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Primary dysferlinopathies are a group of autosomal recessive heterogeneousneuromuscular disorders and are due to mutations in the 55-exon gene, located at 2p13,and encodes the protein dysferlin. There is heterogeneity variability in the clinicalpresentations, which range from limb girdle muscular dystrophy 2B (LGMD2), Miyoshimyopathy and DMAT to isolated hyperCKemia and severe functional disability. InLGMD2B, the proximal muscles of the lower limbs are involved whereas in Miyoshimyopathy (MM) symptoms begin in the posterior muscle compartment of the calf andthey later spread to the upper muscles. In DMAT, the anterior muscle weakness is thefirst symptom to appear progressing rapidly to the lower and upper proximal muscles.The onset of MM and LGMD2B is generally in the teens or early adulthood. CK isalways very high. The morphological findings of primary dysferlinopathies show fiberssize variability, fiber splitting, necrotic and regenerative fibers. The diagnosis of thedisorder is made by the reduction or absence of dysferlin in muscles of the affectedpatients performed by immunohistochemistry and immunoblotting with dysferlinmonoclonal antibodies. The molecular analysis confirms the diagnosis.

Original languageEnglish
Title of host publicationMuscular Dystrophy: Causes and Management
PublisherNova Science Publishers, Inc.
Pages277-304
Number of pages28
ISBN (Print)9781626184602
Publication statusPublished - 2013

Fingerprint

Muscles
Limb-Girdle Muscular Dystrophies
Muscle Weakness
Immunoblotting
Lower Extremity
Exons
Immunohistochemistry
Dysferlinopathy
Mutation
Antibodies
Genes
Proteins

ASJC Scopus subject areas

  • Medicine(all)
  • Neuroscience(all)

Cite this

Vernengo, L., Carrasco, L., Rodríguez, M. M., & Angelini, C. (2013). Dysferlinopathies. In Muscular Dystrophy: Causes and Management (pp. 277-304). Nova Science Publishers, Inc..

Dysferlinopathies. / Vernengo, Luis; Carrasco, Luisa; Rodríguez, María Mirta; Angelini, Corrado.

Muscular Dystrophy: Causes and Management. Nova Science Publishers, Inc., 2013. p. 277-304.

Research output: Chapter in Book/Report/Conference proceedingChapter

Vernengo, L, Carrasco, L, Rodríguez, MM & Angelini, C 2013, Dysferlinopathies. in Muscular Dystrophy: Causes and Management. Nova Science Publishers, Inc., pp. 277-304.
Vernengo L, Carrasco L, Rodríguez MM, Angelini C. Dysferlinopathies. In Muscular Dystrophy: Causes and Management. Nova Science Publishers, Inc. 2013. p. 277-304
Vernengo, Luis ; Carrasco, Luisa ; Rodríguez, María Mirta ; Angelini, Corrado. / Dysferlinopathies. Muscular Dystrophy: Causes and Management. Nova Science Publishers, Inc., 2013. pp. 277-304
@inbook{ac3978c55ebc4c4c8176a52717433766,
title = "Dysferlinopathies",
abstract = "Primary dysferlinopathies are a group of autosomal recessive heterogeneousneuromuscular disorders and are due to mutations in the 55-exon gene, located at 2p13,and encodes the protein dysferlin. There is heterogeneity variability in the clinicalpresentations, which range from limb girdle muscular dystrophy 2B (LGMD2), Miyoshimyopathy and DMAT to isolated hyperCKemia and severe functional disability. InLGMD2B, the proximal muscles of the lower limbs are involved whereas in Miyoshimyopathy (MM) symptoms begin in the posterior muscle compartment of the calf andthey later spread to the upper muscles. In DMAT, the anterior muscle weakness is thefirst symptom to appear progressing rapidly to the lower and upper proximal muscles.The onset of MM and LGMD2B is generally in the teens or early adulthood. CK isalways very high. The morphological findings of primary dysferlinopathies show fiberssize variability, fiber splitting, necrotic and regenerative fibers. The diagnosis of thedisorder is made by the reduction or absence of dysferlin in muscles of the affectedpatients performed by immunohistochemistry and immunoblotting with dysferlinmonoclonal antibodies. The molecular analysis confirms the diagnosis.",
author = "Luis Vernengo and Luisa Carrasco and Rodr{\'i}guez, {Mar{\'i}a Mirta} and Corrado Angelini",
year = "2013",
language = "English",
isbn = "9781626184602",
pages = "277--304",
booktitle = "Muscular Dystrophy: Causes and Management",
publisher = "Nova Science Publishers, Inc.",

}

TY - CHAP

T1 - Dysferlinopathies

AU - Vernengo, Luis

AU - Carrasco, Luisa

AU - Rodríguez, María Mirta

AU - Angelini, Corrado

PY - 2013

Y1 - 2013

N2 - Primary dysferlinopathies are a group of autosomal recessive heterogeneousneuromuscular disorders and are due to mutations in the 55-exon gene, located at 2p13,and encodes the protein dysferlin. There is heterogeneity variability in the clinicalpresentations, which range from limb girdle muscular dystrophy 2B (LGMD2), Miyoshimyopathy and DMAT to isolated hyperCKemia and severe functional disability. InLGMD2B, the proximal muscles of the lower limbs are involved whereas in Miyoshimyopathy (MM) symptoms begin in the posterior muscle compartment of the calf andthey later spread to the upper muscles. In DMAT, the anterior muscle weakness is thefirst symptom to appear progressing rapidly to the lower and upper proximal muscles.The onset of MM and LGMD2B is generally in the teens or early adulthood. CK isalways very high. The morphological findings of primary dysferlinopathies show fiberssize variability, fiber splitting, necrotic and regenerative fibers. The diagnosis of thedisorder is made by the reduction or absence of dysferlin in muscles of the affectedpatients performed by immunohistochemistry and immunoblotting with dysferlinmonoclonal antibodies. The molecular analysis confirms the diagnosis.

AB - Primary dysferlinopathies are a group of autosomal recessive heterogeneousneuromuscular disorders and are due to mutations in the 55-exon gene, located at 2p13,and encodes the protein dysferlin. There is heterogeneity variability in the clinicalpresentations, which range from limb girdle muscular dystrophy 2B (LGMD2), Miyoshimyopathy and DMAT to isolated hyperCKemia and severe functional disability. InLGMD2B, the proximal muscles of the lower limbs are involved whereas in Miyoshimyopathy (MM) symptoms begin in the posterior muscle compartment of the calf andthey later spread to the upper muscles. In DMAT, the anterior muscle weakness is thefirst symptom to appear progressing rapidly to the lower and upper proximal muscles.The onset of MM and LGMD2B is generally in the teens or early adulthood. CK isalways very high. The morphological findings of primary dysferlinopathies show fiberssize variability, fiber splitting, necrotic and regenerative fibers. The diagnosis of thedisorder is made by the reduction or absence of dysferlin in muscles of the affectedpatients performed by immunohistochemistry and immunoblotting with dysferlinmonoclonal antibodies. The molecular analysis confirms the diagnosis.

UR - http://www.scopus.com/inward/record.url?scp=84892948804&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892948804&partnerID=8YFLogxK

M3 - Chapter

AN - SCOPUS:84892948804

SN - 9781626184602

SP - 277

EP - 304

BT - Muscular Dystrophy: Causes and Management

PB - Nova Science Publishers, Inc.

ER -